Stonebridge Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-150
| Closed | -$13K | – | 1102 |
|
|
2022
Q1 | $13K | Hold |
150
| – | – | ﹤0.01% | 630 |
|
|
2021
Q4 | $17K | Hold |
150
| – | – | ﹤0.01% | 545 |
|
|
2021
Q3 | $19K | Sell |
150
-150
| -50% | -$19K | ﹤0.01% | 508 |
|
|
2021
Q2 | $40K | Buy |
300
+150
| +100% | +$20K | ﹤0.01% | 509 |
|
|
2021
Q1 | $20K | Buy |
+150
| New | +$20K | ﹤0.01% | 507 |
|
|
2019
Q3 | – | Sell |
-708
| Closed | -$62K | – | 960 |
|
|
2019
Q2 | $62K | Buy |
+708
| New | +$62K | 0.01% | 286 |
|
|
2015
Q3 | – | Sell |
-59,598
| Closed | -$5.01M | – | 155 |
|
|
2015
Q2 | $5.01M | Sell |
59,598
-1,017
| -2% | -$85.5K | 1.93% | 12 |
|
|
2015
Q1 | $4.56M | Buy |
60,615
+1,740
| +3% | +$131K | 1.76% | 13 |
|
|
2014
Q4 | $3.66M | Buy |
58,875
+3,198
| +6% | +$199K | 1.5% | 13 |
|
|
2014
Q3 | $2.9M | Buy |
55,677
+2,481
| +5% | +$129K | 1.28% | 21 |
|
|
2014
Q2 | $2.73M | Buy |
53,196
+2,268
| +4% | +$116K | 1.23% | 27 |
|
|
2014
Q1 | $2.42M | Buy |
50,928
+3,450
| +7% | +$164K | 1.18% | 30 |
|
|
2013
Q4 | $2.06M | Buy |
+47,478
| New | +$2.06M | 1.06% | 34 |
|